Results 331 to 339 of about 420,417 (339)
Some of the next articles are maybe not open access.

Antenatal corticosteroids for low and middle income countries

Seminars in Perinatology, 2019
Antenatal corticosteroids (ACS) are sporadically used in low and middle income countries (LMIC), although their use is considered by the World Health Organization (WHO) as essential for decreasing infant mortality. Presently the WHO recommends the use of ACS only when gestational age is known, delivery is imminent, and the delivery will be in a ...
Alan H, Jobe   +3 more
openaire   +2 more sources

Peripartum cardiomyopathy in low- and middle-income countries

Best Practice & Research Clinical Obstetrics & Gynaecology
Peripartum cardiomyopathy (PPCM) causes pregnancy-associated heart failure, typically during the last month of pregnancy, and up to 6 months post-partum, in women without known cardiovascular disease. PPCM is a global disease, but with a significant geographical variability within and between countries.
Emmanuel C, Ejim   +4 more
openaire   +2 more sources

Maternal and child undernutrition and overweight in low-income and middle-income countries

The Lancet, 2013
R. Black   +10 more
semanticscholar   +1 more source

Cardiovascular Health in Low- and Middle-Income Countries

Current Problems in Cardiology, 2014
The American Heart Association has defined cardiovascular health (CVH) through 7 metrics, including 3 health behaviors (tobacco use, diet, and physical activity) and 4 health factors (body weight, blood pressure, blood cholesterol, and blood glucose). Although the American Heart Association has championed the measurement, monitoring, and messaging of ...
openaire   +2 more sources

Precision Medicine in Low‐ and Middle‐Income Countries

Clinical Pharmacology & Therapeutics, 2019
Nathalie K, Zgheib   +3 more
openaire   +2 more sources

Obesity in Low- and Middle-Income Countries: Burden, Drivers, and Emerging Challenges.

Annual Review of Public Health, 2017
N. Ford, Shivani A. Patel, K. Narayan
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy